of the hypoxia signalling pathway. In this study, we examine the effect of exercise on muscle function in young and old mice and explore the role of hypoxia pathway in mediating exercise-induced functional improvement. Young (3 months) and old (22-24 months) mice underwent either aerobic exercise training on a treadmill for 8 weeks (40 minutes per run, 3 times weekly, at 8 meters/min at a 15 degree inclination) or no exercise as a control. Maximum running speed and distance were measured pre-and post-exercise. Following training, there was a significant increase in both maximal speed (20%, p<0.05) and distance (2.5 fold) running in young mice which exercised versus young control (p<0.01). Old mice following exercise training did exhibit any improvement versus the old control group. Notably, protein levels of aryl hydrocarbon receptor nuclear translocator (ARNT), a critical regulator of hypoxia signalling, was 4.7-fold lower in the muscle of old mice after exercise as compared to young (p<0.01). To evaluate further whether loss of hypoxia signaling limits response to exercise, we developed a mouse with an inducible, skeletal muscle specific ARNT knockout (ARNT mKO). ARNT mKO mice exhibited no improvement in either maximal running speed or distance following exercise training. In contrast, littermate controls, with normal ARNT levels, exhibited improvement in both maximal speed and distance running following exercise. Our results suggest that an aging-associated decline ARNT and hypoxia signalling may limit aerobic exercise benefits. Methods to quantify biological aging have been proposed to measure age-related decline in system integrity for population surveillance and evaluation of geroprotective therapies. However, quantifications of biological aging have been littlestudied in geriatric populations. We conducted analysis of three clinical-biomarker-algorithm methods to quantify biological aging, the Klemera-Doubal Method (KDM) Biological Age, homeostatic dysregulation (HD), and Levine Method (LM) Biological Age in a cohort of N=1,374 older adults aged 71-102 years (35% male, 52% African American), the Duke-EPESE. We parameterized algorithms from analysis of US NHANES data (N=36,207). We conducted criterion validity analyses using measures of disability and mortality as end-points. We analyzed counts of ADLs and iADLs using negative binomial regression. We analyzed time-to-death using Cox regression. Models were adjusted for age, sex, and race/ethnicity. We evaluated algorithms derived from analysis of different biomarker groupings. We also compared algorithms derived from analysis of mixed age and race/ethnicity samples to algorithms derived from older-age (65+) and individual race/ethnicity samples. Duke-EPESE participants with older KDM Biological Age reported dependence in more ADLs and iADLs, and were at increased risk of death (ADL IRR=1.19 Aging is the inevitable, irreversible decline in function on the cellular and organ level leading to increased incidence of the most frequent diseases such as cancer and cardiovascular disease, that occurs over time. whereas the molecular mechanisms of senescence remain largely unknown. Here we identified that a novel long noncoding RNA, Morrbid was significantly decreased in different organs of aged mice, such as heart, liver, spleen, lung, kidney and brain. Interestingly, the telomeres length of Morrbid KO mice were significantly shorted than the WT mice at the same age. We also found that Morrbid was steeply decreased in a natural mouse cardiac myocyte senescence model. The senescence of mouse cardiac myocytes was effectively attenuated by Morrbid over-expression shown by the decreased β-galactosidase staining, increased telomere activity, decreased production of ROS and decreased cell apoptosis, but was enhanced by Morrbid knockdown. The results suggest that Morrbid is a critical regulator in senescence and could be used as a novel diagnostic biomarker for it, and a new therapeutic target for diverse diseases. The process of aging is multifactorial and therefore single interventions may be unlikely to attenuate the myriad pathologies. Plasma contains many beneficial factors which have been shown in animal models to ameliorate multiple age-related deficits across varied organ systems, including the brain. We demonstrated that human plasma from young 18-22-year-old donors reverses age-related cognitive decline and enhances hippocampal neurogenesis and cell survival in aged immunocompromised mice, while plasma from aged individuals (62-68 years old) has detrimental effects in young mice. Utilizing cell-based assays we identified a human plasma fraction (PF) which enhanced neuronal outgrowth and synaptic connectivity. We demonstrate that PF administration provides benefits beyond those observed with whole plasma treatment, resulting in decreased brain inflammation, increased synaptic density and neuronal activation.
QUANTIFICATIONS OF BIOLOGICAL AGING PREDICT DISABILITY AND MORTALITY IN OLDER ADULTS IN THE DUKE EPESE
Methods to quantify biological aging have been proposed to measure age-related decline in system integrity for population surveillance and evaluation of geroprotective therapies. However, quantifications of biological aging have been littlestudied in geriatric populations. We conducted analysis of three clinical-biomarker-algorithm methods to quantify biological aging, the Klemera-Doubal Method (KDM) Biological Age, homeostatic dysregulation (HD), and Levine Method (LM) Biological Age in a cohort of N=1,374 older adults aged 71-102 years (35% male, 52% African American), the Duke-EPESE. We parameterized algorithms from analysis of US NHANES data (N=36,207). We conducted criterion validity analyses using measures of disability and mortality as end-points. We analyzed counts of ADLs and iADLs using negative binomial regression. We analyzed time-to-death using Cox regression. Models were adjusted for age, sex, and race/ethnicity. We evaluated algorithms derived from analysis of different biomarker groupings. We also compared algorithms derived from analysis of mixed age and race/ethnicity samples to algorithms derived from older-age (65+) and individual race/ethnicity samples. Duke-EPESE participants with older KDM Biological Age reported dependence in more ADLs and iADLs, and were at increased risk of death (ADL IRR=1.19 [1.12, 1.27 Aging is the inevitable, irreversible decline in function on the cellular and organ level leading to increased incidence of the most frequent diseases such as cancer and cardiovascular disease, that occurs over time. whereas the molecular mechanisms of senescence remain largely unknown. Here we identified that a novel long noncoding RNA, Morrbid was significantly decreased in different organs of aged mice, such as heart, liver, spleen, lung, kidney and brain. Interestingly, the telomeres length of Morrbid KO mice were significantly shorted than the WT mice at the same age. We also found that Morrbid was steeply decreased in a natural mouse cardiac myocyte senescence model. The senescence of mouse cardiac myocytes was effectively attenuated by Morrbid over-expression shown by the decreased β-galactosidase staining, increased telomere activity, decreased production of ROS and decreased cell apoptosis, but was enhanced by Morrbid knockdown. The results suggest that Morrbid is a critical regulator in senescence and could be used as a novel diagnostic biomarker for it, and a new therapeutic target for diverse diseases. The process of aging is multifactorial and therefore single interventions may be unlikely to attenuate the myriad pathologies. Plasma contains many beneficial factors which have been shown in animal models to ameliorate multiple age-related deficits across varied organ systems, including the brain. We demonstrated that human plasma from young 18-22-year-old donors reverses age-related cognitive decline and enhances hippocampal neurogenesis and cell survival in aged immunocompromised mice, while plasma from aged individuals (62-68 years old) has detrimental effects in young mice. Utilizing cell-based assays we identified a human plasma fraction (PF) which enhanced neuronal outgrowth and synaptic connectivity. We demonstrate that PF administration provides benefits beyond those observed with whole plasma treatment, resulting in decreased brain inflammation, increased synaptic density and neuronal activation.
BENEFICIAL EFFECTS OF A PLASMA FRACTION ON NEUROGENESIS FOR AGE-RELATED COGNITIVE DISORDERS
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